MSATL2021

Chairs

 

Professor William CarrollProfessor William Carroll

Professor William Carroll is a Consultant Neurologist in the Department of Neurology and Neurophysiology at the Sir Charles Gairdner Hospital in Perth, Western Australia. He is also Chair of the Multiple Sclerosis Research Australia International Research Review Board, a previous chair of the Multiple Sclerosis Research Australia Management Council, a previous President of the Australian and New Zealand Association of Neurologists and President of the XV111 World Congress of Neurology 2005.

He is currently the Asia Pacific editor of Multiple Sclerosis Journal, President of the World Federation of Neurology and foundation Vice President of the Pan Asian Committee for Research and Treatment of MS (PACTRIMS) and a member of the steering committee of the International Progressive MS Alliance (IPMSA). His principal research activity has been in demyelinating disease, both multiple sclerosis and of the biology of demyelination and remyelination in experimental optic neuropathy.


Professor Gavin GiovannoniProfessor Gavin Giovannoni

Gavin Giovannoni is an academic neurologist based at Barts and The London School of Medicine and Dentistry, Queen Mary University London. His current research is focused on Epstein Barr virus as a possible cause of multiple sclerosis, MS-related neurodegeneration, biomarker discovery & validation, and MS clinical outcomes. Gavin is also an avid reader, blogger, runner, gardener, husband, father, dog-owner, cook and wine & food lover.


Professor Klaus SchmiererProfessor Klaus Schmierer

Dr Schmierer is a Professor of Neurology at The Blizard Institute, Barts and The London School of Medicine & Dentistry (Queen Mary University of London), and a Consultant Neurologist at The Royal London Hospital, Barts Health NHS Trust, where he is the Research Lead for Neurology, and the Clinical Lead of the Neuroscience Day Case Unit & BartsMS.

After completing his training in neurology at the Charité Hospital (Humboldt University Berlin), he moved to London to pursue a career in academic neurology, initially as a Research Fellow & Clinical Associate, and from 2005 as a Wellcome Intermediate Clinical Fellow at the UCL Institute of Neurology, and Consultant Neurologist at The National Hospital, Queen Square. Following appointments in 2009 at QMUL and Barts Health he moved to his current position in east London.

Ever since starting his career in neurology, Dr Schmierer has maintained a focus on inflammatory demyelination, including research into the pathology, pathophysiology, MRI detection & measurement, and disease control in people with MS, the (differential) diagnosis & monitoring of MS, and investigator-led and commercial clinical trials. He advocates a pro-active treatment approach at all stages of MS.

Dr Schmierer is the Lead for MS at the National Institute of Health Research North Thames Clinical Research Network and serves on the Scientific Strategy Committee of the UK MS Register. He has advised the EMA, MHRA, and NICE on new drugs for

MS. Dr Schmierer is the CI of ChariotMS and AttackMS, and a member of the steering committee of MAGNIFY-MS. His research has been supported by Barts Charity, HEFCE, Wellcome Trust, MRC/NIHR-EME, National MS Society (US), Royal College of Radiologists, UK MS Society, and collaborations with industry.


Professor Emmanuelle WaubantProfessor Emmanuelle Waubant

Dr. Emmanuelle L. Waubant is a neurologist who specializes in treating patients with multiple sclerosis (MS). She serves as director of the UCSF Regional Pediatric Multiple Sclerosis Center.

Dr. Waubant's research focuses on new treatments for MS. She also studies environmental and genetic risk factors, including in children with the disease.

A native of France, Waubant earned her medical degree at the Lille University School of Medicine and completed a residency in neurology at Toulouse University Hospital, where she was chief resident as well as junior faculty for two years. She completed fellowships in neuroimmunology and clinical neuroimmunology at UCSF and then returned to her native country to head a clinical research center at the Pitié-Salpêtrière University Hospital in Paris. She joined the UCSF Multiple Sclerosis Center in 2001.

Waubant serves on the clinical care committee of the National Multiple Sclerosis Society's local chapter and on the translational research review committee for the society's national office. She chairs the clinical trial task force and serves on the steering committee of the International Pediatric Multiple Sclerosis Study Group.

A prominent contributor to scientific journals in her field, Waubant is one of two chief editors of Multiple Sclerosis and Related Disorders, and she is MS section editor for Annals of Clinical and Translational Neurology.